Skip to main content

Table 3 Reasons for allowing and refusing GS

From: Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland

 n%a
Reasons for allowing GS (n=864b)
 Willingness to lower medicine expenses65275.5
 The prescribed medicine was unavailable at the pharmacy26630.8
 The previously used medicine was unavailable at the pharmacy23727.4
 Pharmacist’s recommendation22526.0
 Dissatisfaction with the medicine that was used before313.6
 Physician’s recommendation232.7
 Some other reasonc394.5
Reasons for refusing GS (n=528d)
 Too small a difference in price of the interchangeable medicines33463.3
 Satisfaction with the medicine used before31860.2
 The interchangeable medicine that the customer wanted was unavailable at the pharmacy7213.6
 Customer’s concern that the interchangeable medicine will be less effective than the medicine used before6712.7
 Choice of interchangeable medicine was made during physician visit5911.2
 Too many switches before a suitable one was found489.1
 Customer’s concern that the interchangeable medicine will be less effective than the one prescribed by the physician428.0
 Customer’s medicines are subject to special reimbursemente, so the customer would not have benefited from the saving264.9
 Customer did not receive enough information about different alternative products224.2
 Fear of mixing up medicines152.8
 Some other reasonf7213.6
  1. aRespondents may have chosen several options
  2. bOnly customers who had experience with allowing GS answered this question. However, some did not report reasons for allowing GS
  3. cE.g. willingness to purchase a Finnish product, the medicine was substituted in order to receive full reimbursement, and the previously used medicine was no longer manufactured
  4. dOnly customers who had experience with refusing GS answered this question. However, some did not report reasons for refusing GS
  5. eIn Finland, reimbursements for medicines are divided into three rates: basic reimbursement (40% of the prescription medicine price), lower special reimbursement (65%) and higher special reimbursement (100%, the customer pays a €4.50 co-payment per prescription medicine purchase) [37]
  6. fE.g. the cost of the medicine is not paid by the customer, willingness to purchase a Finnish product, handy packet, and customer’s experience or fear of side effects
\